Dgenx Co., Ltd. (KOSDAQ:113810)
927.00
-32.00 (-3.34%)
At close: Aug 1, 2025, 3:30 PM KST
Ligand Pharmaceuticals Market Cap
Dgenx has a market cap or net worth of 30.96 billion as of August 8, 2025. Its market cap has increased by 0.21% in one year.
Market Cap
30.96B
Enterprise Value
36.37B
Revenue
89.67B
Ranking
n/a
PE Ratio
7.03
Stock Price
$927.00
Market Cap Chart
Since November 22, 2012, Dgenx's market cap has decreased from 43.44B to 30.96B, a decrease of -28.71%. That is a compound annual growth rate of -2.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 30.96B | -40.31% |
Dec 30, 2024 | 51.88B | 35.20% |
Dec 28, 2023 | 38.37B | 23.27% |
Dec 29, 2022 | 31.13B | 4.95% |
Dec 30, 2021 | 29.66B | 24.69% |
Dec 30, 2020 | 23.79B | 24.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 450.21T |
SK hynix | 178.45T |
LG Energy Solution | 89.86T |
Samsung Biologics | 73.38T |
Hanwha Aerospace | 48.16T |
Hyundai Motor Company | 46.02T |
Doosan Enerbility | 42.46T |
KB Financial Group | 42.10T |